1 -Line Trials

1st-Line Trials
Study of Efficacy and Safety of Sunitinib Given on an Individualized
Schedule
NCT01499121
Tom Baker Cancer Centre
Cross Cancer Institute
BCCA - Vancouver Centre
QEII Health Sciences Centre
Juravinski Cancer Centre
London Health Sciences Centre
Durham Regional Cancer Centre
Ottawa Hospital Cancer Centre
Sunnybrook
Princess Margaret Cancer Centre
Notre Dame Hospital
Calgary
Edmonton
Vancouver
Halifax
Hamilton
London
Oshawa
Ottawa
Toronto
Toronto
Montreal
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Combination Chemotherapy, Radiation Therapy, and/or Surgery in
Treating Patients With High-Risk Kidney Tumors
NCT00335556
Alberta Children’s Hospital
University of Alberta Hospital
Children’s & Women’s Hospital of BC
CancerCare Manitoba
Janeway Children's Health &
Rehabilitation Centre
IWK Health Centre
McMaster Children’s Hospital
Cancer Centre of Southeastern Ontario
Children's Hospital of Western Ontario
Children's Hospital of Eastern Ontario
Hospital for Sick Children
Hopital Sainte Justine
Centre Hospitalier Universitaire de
Quebec
Saskatoon Cancer Centre
Updated: February 2, 2014
Calgary
Edmonton
Vancouver
Winnipeg
St. John’s
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Halifax
Hamilton
Kingston
London
Ottawa
Toronto
Montreal
Quebec
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Saskatoon
Recruiting
A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear
Cell or Papillary Histology
NCT01672775
Cross Cancer Institute
BCCA - Vancouver Centre
London Health Sciences Centre
Jewish General Hospital
Edmonton
Vancouver
London
Montreal
Recruiting
Recruiting
Not Yet Recruiting
Recruiting
Combination Chemotherapy and Surgery in Treating Young Patients With
Wilms Tumor
NCT00945009
Alberta Children’s Hospital
Children’s & Women’s Hospital of BC
CancerCare Manitoba
IWK Health Centre
McMaster Children’s Hospital
Cancer Centre of Southeastern Ontario
Children's Hospital of Eastern Ontario
Hospital for Sick Children
Montreal’s Children’s Hospital
Hopital Sainte Justine
Centre Hospitalier Universitaire de
Quebec
Saskatoon Cancer Centre
Calgary
Vancouver
Winnipeg
Halifax
Hamilton
Kingston
Ottawa
Toronto
Montreal
Montreal
Quebec
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Saskatoon
Recruiting
A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in
Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR
Effect) (SUPER)
NCT01014065
Cross Cancer Institute
Updated: February 2, 2014
Edmonton
Recruiting
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus
Standard Treatment of Advanced Renal Cell Carcinoma (RCC) (ADAPT)
NCT01582672
Hamilton Health Sciences Centre
Jewish General Hospital
Hopital Notre Dame (CHUM)
CancerCare Manitoba
Updated: February 2, 2014
Hamilton
Montreal
Montreal
Winnipeg
Recruiting
Recruiting
Recruiting
Recruiting